160 related articles for article (PubMed ID: 37280656)
1. SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1.
Zhang W; Long J; Tang P; Chen K; Guo G; Yu Z; Lin J; Liu L; Zhan R; Xu Z
Biomark Res; 2023 Jun; 11(1):58. PubMed ID: 37280656
[TBL] [Abstract][Full Text] [Related]
2. SYT7 plays a role in promoting thyroid cancer by mediating HMGB3 ubiquitination.
Dong S; Pan J; Shen YB; Zhu LX; Chen L; Zhu F; Li H; Shen HX; Xia Q; Wu YJ; Xie XJ
Endocr Relat Cancer; 2022 Mar; 29(4):175-189. PubMed ID: 35073278
[TBL] [Abstract][Full Text] [Related]
3. KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2.
Zhong L; Dong Y; Liu S
Mol Carcinog; 2024 May; ():. PubMed ID: 38818892
[TBL] [Abstract][Full Text] [Related]
4. USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by inhibiting STUB1-induced NFAT5 ubiquitination.
Chen B; Zhao Y; Xu S; Jiang F; Nie Y; Tang A; Zhou Q
Ann Hematol; 2024 Feb; 103(2):533-544. PubMed ID: 37950051
[TBL] [Abstract][Full Text] [Related]
5. Synaptotagmin 7 in twist-related protein 1-mediated epithelial - Mesenchymal transition of non-small cell lung cancer.
Liu X; Li C; Yang Y; Liu X; Li R; Zhang M; Yin Y; Qu Y
EBioMedicine; 2019 Aug; 46():42-53. PubMed ID: 31395502
[TBL] [Abstract][Full Text] [Related]
6. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivo.
Lin F; Wu D; Fang D; Chen Y; Zhou H; Ou C
Inflamm Res; 2019 Sep; 68(9):739-749. PubMed ID: 31218443
[TBL] [Abstract][Full Text] [Related]
7. SYT7 (synaptotagmin 7) promotes cervical squamous cell carcinoma.
Huang J; Xu W; Huang Q; Chen E; Chen J
Heliyon; 2024 Feb; 10(3):e24806. PubMed ID: 38314285
[TBL] [Abstract][Full Text] [Related]
8. Synaptotagmin7 Is Overexpressed In Colorectal Cancer And Regulates Colorectal Cancer Cell Proliferation.
Wang K; Xiao H; Zhang J; Zhu D
J Cancer; 2018; 9(13):2349-2356. PubMed ID: 30026831
[No Abstract] [Full Text] [Related]
9. Silencing of synaptotagmin 7 regulates osteosarcoma cell proliferation, apoptosis, and migration.
Wu Z; Sun Z; Huang R; Zang D; Wang C; Yan X; Yan W
Histol Histopathol; 2020 Mar; 35(3):303-312. PubMed ID: 31631310
[TBL] [Abstract][Full Text] [Related]
10. Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.
Wang C; Wang Y; Liu C; Meng X; Hang Z
Bioengineered; 2022 Apr; 13(4):9495-9507. PubMed ID: 35389773
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis.
Xiao B; Li J; Fan Y; Ye M; Lv S; Xu B; Chai Y; Zhou Z; Wu M; Zhu X
Mol Med Rep; 2017 Dec; 16(6):9017-9022. PubMed ID: 28990113
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of COP1 in chronic lymphocytic leukemia cells for promotion of cell proliferation and tumorigenicity.
Fu C; Gong Y; Shi X; Shi H; Wan Y; Wu Q; Xu K
Oncol Rep; 2016 Mar; 35(3):1493-500. PubMed ID: 26717976
[TBL] [Abstract][Full Text] [Related]
13. shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8.
Liu R; Liu R; Guo Z; Ren J; Huang J; Luo Q; Tan Q
Cell Death Dis; 2022 Aug; 13(8):685. PubMed ID: 35933405
[TBL] [Abstract][Full Text] [Related]
14. KIAA0101 knockdown inhibits cell proliferation and induces cell cycle arrest and cell apoptosis in chronic lymphocytic leukemia cells.
Zhang Q; Yuan J; Liu Y; Liu X; Lv T; Zhou K; Song Y
Ann Transl Med; 2021 Mar; 9(6):487. PubMed ID: 33850884
[TBL] [Abstract][Full Text] [Related]
15. SENP2 exerts an anti‑tumor effect on chronic lymphocytic leukemia cells through the inhibition of the Notch and NF‑κB signaling pathways.
Chen XL; Wang SF; Liang XT; Liang HX; Wang TT; Wu SQ; Qiu ZJ; Zhan R; Xu ZS
Int J Oncol; 2019 Feb; 54(2):455-466. PubMed ID: 30431078
[TBL] [Abstract][Full Text] [Related]
16. CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p/LPL axis.
Wu Z; Gu D; Wang R; Zuo X; Zhu H; Wang L; Lu X; Xia Y; Qin S; Zhang W; Xu W; Fan L; Li J; Jin H
Exp Hematol Oncol; 2022 Sep; 11(1):51. PubMed ID: 36064433
[TBL] [Abstract][Full Text] [Related]
17. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
18. Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia.
Zhou K; Zhang W; Zhang Q; Gui R; Zhao H; Chai X; Li Y; Wei X; Song Y
Oncotarget; 2017 Apr; 8(15):25469-25481. PubMed ID: 28424416
[TBL] [Abstract][Full Text] [Related]
19. SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC.
Fu Y; Tian G; Zhang Z; Yang X
Cancer Cell Int; 2021 Dec; 21(1):696. PubMed ID: 34930262
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway.
Xia L; Wu L; Bao J; Li Q; Chen X; Xia H; Xia R
Biochem Biophys Res Commun; 2018 Sep; 503(1):385-390. PubMed ID: 29902450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
